Special Session 4
(1) ISMAN-What’s the Updated Guidelines for ACS Management, inahea, 2018, isman (2) JARIR-CEA Ticagrelor (InaHEA 2 Nov2018 – Jakarta) – Copy
Special Session 3
(1) ATIK NURWAHYUNI-INAHEA 2018 EVALUASI CMG O DAN CMG I (2) DR ANDI-BPJS_INAHEA_THE CHALLENGES IN INA CBG2 (3) KALSUM KOMARYANI-Progress & Challenges In Developing Native DRG Grouper – INA-HEA (4) LANGBRUNNER-Case Mix Langenbrunner Final Ina HEA (5) RIC MARSHALL Moving to a native grouper for CBGs
Special Session 2
(1) ARYANTHI BARAMULI-Surviving Cancer – INAHEA 2018 (1) (2) dr. Andi Nafsiah-2018 Nov 1 Rising NCDs – InaHEA NM – fin (3) PRASTUTI SOEWONDO-Bu Becky-Cancer RKO vs E-order (4) PROF BUDI-sesi Pembuka_Kanker
Special Session 1
(1) Aida InaHEA 1 Nov 2018 (2) Dr. Dra. L. Rizka Andalucia, M.Pharm, Apt_InaHEA Annual meeting Role of NADFC (3) MALA-InaHEA 011118 ESRD (4) NI MADE AYU SRI RATNA-InaHea (5) Tony Samosir_KPCDI – Materi InaHEA
Short Session 1
(1) Draft – Indonesia NHA 29102018
Plenary Session 4
(1) BHidayat Remedial JKN – ASM (2) ed.InaHEA-Restrukturisasi JKN(1) (3) INAHEA BPJS Kesehatan – 011118_edit -FI (4) PAPARAN BU YOUT INAHEA
Plenary Session 3
(1) Dasar Pemilihan Obat Formularium dan Rasionalisasi Penggunaannya kirim (2) Sarah-INAHEA November 1 (3) Equity in decision making_InaHEA_MG 011118
Plenary Session 2
(1) Andrew Rintoul – 2018Jakarta (2) Brendon slides for InaHEA (3) HTAi_SocietyPresentation_IECAConference_31October2018 (1) (4) InaHEA HTA INDONESIA
Plenary Session 1
(1) plenary final_kreif (2) InaHEA plenary GHE marc (3) Impact Evaluation of the 2014 National Health Insurance